Multiple groups in the early 2000s carried out an extremely comprehensive study of different types of skin cancer using immunohistochemistry, providing strong evidence for high expression of p63 in virtually all types of non-melanoma skin cancer, including pre-cancerous lesions as well as rare forms of squamous cell carcinoma. Here, TP63 is linked to squamous cell carcinoma.